<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="109388">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02072564</url>
  </required_header>
  <id_info>
    <org_study_id>DYP-HAB-2010-01</org_study_id>
    <secondary_id>Desarrollos y proyectos en RA</secondary_id>
    <nct_id>NCT02072564</nct_id>
  </id_info>
  <brief_title>Influence of Diet and Lifestyle Factors on the Results of the IVF</brief_title>
  <official_title>Pilot Study on the Influence of the Different Components of the Diet and Different Habits (Tobacco, Alcohol, Physical Exercise, Occupation) Results of IVF-ICSI</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Merck Serono International SA</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau</source>
  <oversight_info>
    <authority>Spain: Ministry of Health and Consumption</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is study the possible relationship between various lifestyle
      habits of men and women (age, body mass index, diet, exercise, alcohol, tobacco, coffee,
      etc..) and live birth rate after in vitro fertilization-intracytoplasmatic injection
      (IVF-ICSI).
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2012</start_date>
  <completion_date type="Anticipated">June 2014</completion_date>
  <primary_completion_date type="Actual">September 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational [Patient Registry]</study_type>
  <study_design>Observational Model: Case-Only, Time Perspective: Prospective</study_design>
  <target_duration>9 Months</target_duration>
  <primary_outcome>
    <measure>Live birth rate</measure>
    <time_frame>One year</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pregnancy rate</measure>
    <time_frame>1 month</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of mature oocytes</measure>
    <time_frame>Two weeks</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fertilization rate</measure>
    <time_frame>Two weeks</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cancelation rate</measure>
    <time_frame>One month</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total dose</measure>
    <time_frame>One month</time_frame>
    <safety_issue>No</safety_issue>
    <description>Total dose of gonadotrophins needed to stimulate the follicular growth</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total Sperm count</measure>
    <time_frame>Two weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>Total number of spermatozoa in the seminal and number of spermatozoa/ml</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Abortion rate</measure>
    <time_frame>16 weeks</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hyperstimulation rate</measure>
    <time_frame>One month</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Moderate and severe hyperstimulation</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">600</enrollment>
  <condition>In Vitro Fertilization (IVF)</condition>
  <arm_group>
    <arm_group_label>IVF</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Test</intervention_name>
    <arm_group_label>IVF</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The study sample is obtained from the population of infertile couples who meet the
        criteria for inclusion in a protocol for controlled ovarian stimulation for IVF/ICSI.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Couples who want a pregnancy

          -  Mediterranean or Caucasian Ethnicity.

          -  Infertility to justify treatment with IVF / ICSI-TEI.

          -  First cycle of IVF / ICSI.

          -  Between 18 and 37 years (inclusive)

          -  Presence of one or both ovaries and uterus can withstand embryo implantation and
             pregnancy.

          -  Body mass index (BMI) &lt;40.

          -  Absence of pregnancy before starting ovarian stimulation.

          -  Having given their written consent.

        Exclusion Criteria:

          -  Clinically important disease.

          -  Inclusion in previous cycles of assisted reproduction.

          -  Unexplained vaginal bleeding.

          -  Any contraindication to become pregnant.

          -  Known allergy to preparations of gonadotropins or its excipients.

          -  Patients undergoing oocyte donation cycles  -
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>37 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Juan José Espinós-Gómez, MD</last_name>
    <phone>+34607163031</phone>
    <email>jespinos@santpau.cat</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hospital de la Santa Creu i Sant Pau</name>
      <address>
        <city>Barcelona</city>
        <zip>08025</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>JUAN JOSE ESPINOS GOMEZ, MD</last_name>
      <phone>607163031</phone>
      <email>jespinos@santpau.cat</email>
    </contact>
    <contact_backup>
      <phone>607163031</phone>
    </contact_backup>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>February 2014</verification_date>
  <lastchanged_date>February 25, 2014</lastchanged_date>
  <firstreceived_date>September 24, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau</investigator_affiliation>
    <investigator_full_name>Juan Jose Espinos Gomez</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>patients</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
